• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[干扰素——生物学原理与临床应用]

[Interferons--biologic principles and clinical uses].

作者信息

Jacobsen H, Kirchner H

出版信息

Klin Padiatr. 1985 Jul-Aug;197(4):263-7. doi: 10.1055/s-2008-1033980.

DOI:10.1055/s-2008-1033980
PMID:3930830
Abstract

Interferons are components of the nonspecific defense system. Their most prominent biological roles are the antiviral, the antiproliferative, and the immunoregulatory activities. However, their primary functions within the organism remains to be determined. Three types of IFNs have been described so far (IFN alpha, IFN beta, IFN gamma). They possess similar but not necessarily identical biological activity. Interferons resemble peptide hormones and growth factors in that they bind to receptors on the cell surface, exert their activity through a postulated "second messenger" and are effective at picomolar concentrations. Interferons have been used as therapeutic agents in viral and malignant diseases with encouraging results in some patients. However, in only few instances interferon may become the standard therapeutic regimen. Since novel therapeutic approaches for cancer and viral disease are urgently needed, additional clinical trials with interferons seem to be justified. These have become feasible because sufficient amounts of pure interferon are available by novel production techniques based on modern biotechnology.

摘要

干扰素是非特异性防御系统的组成部分。它们最显著的生物学作用是抗病毒、抗增殖和免疫调节活性。然而,它们在生物体内的主要功能仍有待确定。到目前为止,已描述了三种类型的干扰素(α干扰素、β干扰素、γ干扰素)。它们具有相似但不一定相同的生物学活性。干扰素类似于肽类激素和生长因子,因为它们与细胞表面的受体结合,通过假定的“第二信使”发挥其活性,并且在皮摩尔浓度下有效。干扰素已被用作治疗病毒和恶性疾病的药物,在一些患者中取得了令人鼓舞的结果。然而,只有在少数情况下,干扰素可能成为标准治疗方案。由于迫切需要针对癌症和病毒疾病的新治疗方法,因此进行更多关于干扰素的临床试验似乎是合理的。由于基于现代生物技术的新生产技术能够获得足够量的纯干扰素,这些试验已变得可行。

相似文献

1
[Interferons--biologic principles and clinical uses].[干扰素——生物学原理与临床应用]
Klin Padiatr. 1985 Jul-Aug;197(4):263-7. doi: 10.1055/s-2008-1033980.
2
[The interferon system. A review of biological principles and clinical uses].[干扰素系统。生物学原理与临床应用综述]
Z Gesamte Inn Med. 1986 Nov 15;41(22):613-8.
3
[Interferon--properties and action].[干扰素——特性与作用]
Wiad Lek. 1989;42(19-21):1086-91.
4
Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.人类干扰素(IFN)介导免疫的先天性缺陷:对IFN-α/β、IFN-γ和IFN-λ在宿主防御中各自作用的见解。
Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x.
5
[Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].[干扰素:生理学、药理学及药物治疗学视角]
J Pharmacol. 1983;14 Suppl 3:105-16.
6
Interferons, interferon-like cytokines, and their receptors.干扰素、类干扰素细胞因子及其受体。
Immunol Rev. 2004 Dec;202:8-32. doi: 10.1111/j.0105-2896.2004.00204.x.
7
Independent evolution of antiviral and growth-modulating activities of interferon.干扰素抗病毒和生长调节活性的独立进化。
J Biol Response Mod. 1985 Oct;4(5):447-59.
8
[Current status of interferon therapy].[干扰素治疗的现状]
Wien Med Wochenschr. 1986 Apr 30;136(7-8):163-72.
9
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).干扰素-γ:生物学功能与丙型肝炎病毒治疗(I/II型)(共两部分,此为第一部分)
Clin Ter. 2006 Jul-Aug;157(4):377-86.
10
[Interferon in the treatment of viral, neoplastic and immunologic diseases].
Patol Pol. 1984 Jul-Sep;35(3):245-61.